Total Payments
$3,104
2024 Payments
$531.95
Companies
5
Transactions
28
Medicare Patients
386
Medicare Billing
$121,236
Payment Breakdown by Category
Food & Beverage$3,104 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,104 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,727 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $485.41 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $444.77 | 4 | $0 (2023) |
| Johnson & Johnson Health Care Systems Inc. | $228.10 | 2 | $0 (2024) |
| Eisai Inc. | $219.13 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $531.95 | 5 | Janssen Pharmaceuticals, Inc ($241.82) |
| 2023 | $1,217 | 10 | Janssen Pharmaceuticals, Inc ($533.26) |
| 2022 | $490.54 | 5 | Janssen Pharmaceuticals, Inc ($389.79) |
| 2021 | $229.84 | 2 | Teva Pharmaceuticals USA, Inc. ($119.11) |
| 2020 | $83.33 | 1 | Teva Pharmaceuticals USA, Inc. ($83.33) |
| 2019 | $106.50 | 1 | Janssen Pharmaceuticals, Inc ($106.50) |
| 2018 | $124.50 | 1 | Janssen Pharmaceuticals, Inc ($124.50) |
| 2017 | $320.26 | 3 | Janssen Pharmaceuticals, Inc ($220.27) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: Neuroscience | ||||||
| 05/14/2024 | Johnson & Johnson Health Care Systems Inc. | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $127.92 | General |
| Category: Neuroscience | ||||||
| 03/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $43.33 | General |
| Category: PSYCHIATRY | ||||||
| 03/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $118.88 | General |
| Category: Neurology | ||||||
| 03/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $118.82 | General |
| Category: Neuroscience | ||||||
| 11/15/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Neurology | ||||||
| 10/26/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.15 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $117.35 | General |
| Category: Central Nervous System | ||||||
| 09/27/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $133.76 | General |
| Category: Neuroscience | ||||||
| 07/31/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $149.42 | General |
| Category: Neuroscience | ||||||
| 05/17/2023 | Johnson & Johnson Health Care Systems Inc. | INVEGA SUSTENNA (Drug), SPRAVATO, TECVAYLI | Food and Beverage | In-kind items and services | $100.18 | General |
| Category: Neuroscience | ||||||
| 03/04/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $100.25 | General |
| Category: Neurology | ||||||
| 02/20/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $110.98 | General |
| Category: Neuroscience | ||||||
| 02/15/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $120.19 | General |
| Category: PSYCHIATRY | ||||||
| 01/16/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $139.10 | General |
| Category: Neuroscience | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $139.52 | General |
| Category: Neuroscience | ||||||
| 08/31/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $100.75 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Neuroscience | ||||||
| 04/21/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $124.66 | General |
| Category: Neuroscience | ||||||
| 03/31/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $108.62 | General |
| Category: Neuroscience | ||||||
| 11/04/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $119.11 | General |
| Category: Central Nervous System | ||||||
| 11/03/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $110.73 | General |
| Category: Neuroscience | ||||||
| 01/30/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $83.33 | General |
| Category: Central Nervous System | ||||||
| 03/20/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $106.50 | General |
| Category: Neuroscience | ||||||
| 10/25/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $124.50 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 220 | $26,893 | $13,902 |
| 2022 | 3 | 98 | 489 | $62,059 | $29,974 |
| 2021 | 3 | 128 | 636 | $80,605 | $39,530 |
| 2020 | 3 | 119 | 616 | $79,115 | $37,831 |
Total Patients
386
Total Services
1,961
Medicare Billing
$121,236
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 198 | $23,085 | $12,101 | 52.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 22 | $3,808 | $1,802 | 47.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 429 | $50,017 | $23,683 | 47.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 24 | 26 | $6,158 | $3,491 | 56.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 31 | 34 | $5,885 | $2,800 | 47.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 55 | 559 | $65,174 | $31,524 | 48.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 32 | 33 | $7,815 | $4,394 | 56.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 41 | 44 | $7,616 | $3,612 | 47.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 45 | 532 | $62,026 | $30,177 | 48.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 34 | 40 | $9,473 | $3,979 | 42.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 40 | 44 | $7,616 | $3,674 | 48.2% |
About Dr. Mina Ohm, M.D
Dr. Mina Ohm, M.D is a Psychiatry healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609955954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mina Ohm, M.D has received a total of $3,104 in payments from pharmaceutical and medical device companies, with $531.95 received in 2024. These payments were reported across 28 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($3,104).
As a Medicare-enrolled provider, Ohm has provided services to 386 Medicare beneficiaries, totaling 1,961 services with total Medicare billing of $121,236. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Rochester, NY
- Active Since 11/06/2006
- Last Updated 01/12/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609955954
Products in Payments
- INVEGA SUSTENNA (Drug) $1,628
- REXULTI (Drug) $365.22
- SPRAVATO (Drug) $225.32
- Leqembi (Drug) $219.13
- AUSTEDO (Drug) $202.44
- UZEDY (Drug) $124.98
- ABILIFY MAINTENA (Drug) $120.19
- Austedo XR (Drug) $117.35
- INVEGA TRINZA (Drug) $101.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Rochester
Mr. Tulio Ortega, Md, MD
Psychiatry — Payments: $246,543
Psychiatry $246,543
M Ismail, M.d, M.D
Psychiatry — Payments: $50,839
Psychiatry $50,839
Syed Mustafa, Md, MD
Psychiatry — Payments: $26,048
Psychiatry $26,048
Peter Jensen, Md, Abpn, MD, ABPN
Psychiatry — Payments: $19,612
Psychiatry $19,612
Daniel Montville, Md, MD
Psychiatry — Payments: $15,131
Psychiatry $15,131
Mark Frye, Md, MD
Psychiatry — Payments: $12,930
Psychiatry $12,930